Bio Essence Corporation
BIOE
$0.19
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 58.78% | -66.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 58.78% | -66.17% | |||
| Cost of Revenue | 79.08% | -46.07% | |||
| Gross Profit | 47.24% | -72.07% | |||
| SG&A Expenses | 84.36% | -8.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 81.03% | -36.71% | |||
| Operating Income | 29.43% | -79.04% | |||
| Income Before Tax | 30.34% | -79.09% | |||
| Income Tax Expenses | 6.12% | -- | |||
| Earnings from Continuing Operations | 31.50% | -80.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.50% | -80.04% | |||
| EBIT | 29.43% | -79.04% | |||
| EBITDA | 77.35% | -79.03% | |||
| EPS Basic | 21.74% | -83.03% | |||
| Normalized Basic EPS | 23.33% | -82.25% | |||
| EPS Diluted | 21.74% | -90.91% | |||
| Normalized Diluted EPS | 23.33% | -82.25% | |||
| Average Basic Shares Outstanding | 6.64% | 18.26% | |||
| Average Diluted Shares Outstanding | 6.64% | 18.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||